生物仿真目标联合交付系统是从基因组洞察力中设计的,用于精确治疗骨髓瘤
Tianqi Luo1, Zhijin Fan2, Anyu Zeng1
1Department of Musculoskeletal Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 18, 2024
概括
一种新型的联合递送系统通过结合循环素依赖激酶4 (CDK4) 和多ADP-ribose聚合酶 (PARP) 抑制剂来向骨肉瘤. 这种方法增强了药物输送,提高了疗效,并将瘤转化为免疫热状态,以改善治疗结果.
科学领域:
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
背景情况:
- 骨髓瘤治疗面临着由于高异质性和化疗副作用的挑战.
- 基因组分析显示,在骨髓瘤中,有显著的循环素依赖性激酶4 (CDK4) 放大和同源重组修复缺陷.
研究的目的:
- 为骨髓瘤治疗设计一个有针对性的联合交付系统.
- 用金属有机框架 (MOFs) 来解决药物不溶性和提高治疗疗效.
主要方法:
- 骨髓瘤的综合基因组分析.
- 开发基于MOF的CDK4/6和PARP抑制剂的联合递送系统.
- 用B7H3向生物膜涂覆MOF,以提高向性和生物相容性.
主要成果:
- 该系统精确地针对B7H3表达性骨髓瘤.
- 结合的CDK4/6和PARP抑制剂显示出协同作用,损害DNA修复.
- 该系统激活了免疫微环境,增加了CD8+ T细胞的透.
结论:
- 有针对性的仿生联合交付系统为骨髓瘤治疗提供了一个有前途的战略.
- 这种方法有可能与光动力学疗法结合,以增强瘤细胞根除.
- 该系统将骨髓瘤从免疫感冒转化为免疫热瘤,这表明了更广泛的治疗应用.
关键词:
B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3 B7H3同类的重组修复.生物信息学是一种生物信息学.纳米颗粒是一种纳米粒子.骨质肉瘤是骨质肉瘤的一种疾病.更多相关视频
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
9.0K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K